Table 2.
Duration (years) | l-dopa daily dose (mg)2-a | H&Y | UPDRS total score |
---|---|---|---|
3.5 ± 2.2 (1–8) | 296 ± 150 (0–600) | 2.1 ± 0.7 (1–3) | 23.4 ± 8.5 (8–41) |
Mean ± SD (range).
l-dopa was prescribed in combination with peripheral decarboxylase inhibitors.
Duration (years) | l-dopa daily dose (mg)2-a | H&Y | UPDRS total score |
---|---|---|---|
3.5 ± 2.2 (1–8) | 296 ± 150 (0–600) | 2.1 ± 0.7 (1–3) | 23.4 ± 8.5 (8–41) |
Mean ± SD (range).
l-dopa was prescribed in combination with peripheral decarboxylase inhibitors.